Asarfi Hospital Ltd Posts Strong Growth in Q1 FY27; Revenue Rises to 4,734 Lakhs
Asarfi Hospital Ltd has reported its unaudited financial results for the quarter ended June 30, 2026. The hospital saw revenue rise by 3% year-over-year (YoY) to 4,734 Lakhs, while achieving an EBITDA margin of 20% and a PAT margin of 9%.The company released its financial results in newspaper advertisements published on August 8, 2026, in The Times of India, Hindustan, and Dainik Jagran.
Financial Performance Highlights
The unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 are summarized below:| Metric | Standalone Quarter Ended 30.06.2026 (Unaudited) | Consolidated Quarter Ended 30.06.2026 (Unaudited) |
|---|---|---|
| Revenue from Operations | 4,734.47 Lakhs | 4,753.41 Lakhs |
| Other Income | 59.26 Lakhs | 56.59 Lakhs |
| Total Income | 4,793.73 Lakhs | 4,810.00 Lakhs |
| Profit before Taxes | 427.14 Lakhs | 570.62 Lakhs |
| Profit after Taxes | 1,967.73 Lakhs | 1,967.73 Lakhs |
The financial figures for the quarter ended June 30, 2026, also show:
| Metric (in Rs) | Standalone Quarter Ended 30.06.2026 | Consolidated Quarter Ended 30.06.2026 |
|---|---|---|
| Basic EPS (on a share of Rs 10 each) | 2.17 | 1.59 |
Operational Growth and Speciality Focus
The company attributes its growth to better realizations, improved Average Revenue Per Occupied Bed (ARPOB), and an enhanced case mix across both hospital units. A key operational highlight was the rise in Average Operating Procedure (AOP) revenue, which increased 44% YoY.The ARPOB for specialized care saw significant increases:
- Super-Specialty unit ARPOB rose to 2,498 Lakhs.
- Cancer Unit ARPOB reached 31,892 Lakhs.
This performance was driven by high-acuity specialties, including Orthopedics, Neurology, and Gynecology within the Super-Specialty unit. Furthermore, improved traction in Radiotherapy and Oncology contributed to strengthening the overall revenue mix and complexity of care provided.
Stock Price Movement
Asarfi Hospital Ltd. settled at ₹221.85 on Friday, posting a gain of ₹11.55 or 5.49%. The shares moved within an intraday range that stretched from a low of ₹211.40 to a high of ₹223.85.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.